ivascular | Mediathek

Multicenter Randomized Controlled Trial to Assess the Eff ectiveness of Pac litaxel coated
Luminor® Balloon Catheter versus Uncoated Balloon Catheter in the Superficial Femoral and
Popliteal Arteries to Prevent Vessel Restenosis or Reocclusion

öffnen

LINC2020 - Leipzig Interventional Course

Drug-coated balloon angioplasty of femoropopliteal lesions maintained superiority over standard balloon – 2-year results of the randomized EffPac trial

luminor

öffnen

T.I.N.T.I.N. trial : Final 12-month data with the combination of Luminor DCB + iVolution stent in TASC C and D lesions

luminor, iVolution

öffnen

EuroPCR 2019

EFFPAC trial: Effectiveness of Luminor DCB vs. POBA in the SFA: 24-month safety and efficacy outcomes (U. Teichgräber)

luminor

öffnen

ANGIOLITE trial two-year follow-up. Non-inferiority randomized clinical trial comparing the efficacy and safety of Angiolite vs Xience (A. Perez de Prado)

angiolite

öffnen

Angiographic and optical coherence tomography assessment in follow up of a new paclitaxel-eluting balloon, with an ultrasonic nanotechnology drop dosage system, for the treatment of in-stent restenosis (J. de la Torre)

essential

öffnen

LINC 2019 - Leipzig Interventional Course

Best DCB outcomes in SFA TASC A&B lesions: EFFPAC-RCT 12-months follow-up (U. Teichgräber)

luminor

öffnen

24-month outcomes in the EVOLUTION study - Investigating the iVolution stent in fempop lesions (M. Bosiers)

iVolution

öffnen

DCB in SFA complex lesions : 1 + 1 = 3 TINTIN trial first outcomes (K. Deloose)

luminor, iVolution

öffnen

State of the Art of BTK Vessel treatment (S. Sixt)

luminor

öffnen

BIBLIOS STUDY (K. Deloose)

luminor

öffnen

CX Symposium 2018

EffPac-Trial: Effectiveness of LUMINOR® DCB versus POBA in the SFA: 12 months results (U. Teichgräber)

luminor

öffnen

Below-the-knee dedicated sirolimus eluting stent : 6 months results (P. Goverde)

angiolite BTK

öffnen

LINC 2018 - Leipzig Interventional Course

EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions (D. Scheinert)

luminor

öffnen

Is Luminor DCB the best choice for femoropopliteal lesions? EffPac-RCT, 6-month data (U. Teichgräber)

luminor

öffnen

Luminor DCB makes it different and favourable in CLI (LUMINOR registry, 12-month data) (V. Riambau)

luminor

öffnen

Evolution Or is the iVolution stent a better alternative? EVOLUTION 12-month data (M. Bosiers)

iVolution

öffnen

6-month results of real-life use of the latest generation of balloon expandable DES in below-the-knee treatment (P. Goverde)

angiolite BTK

öffnen

Is there still any space left for DES in the BTK area ??? (Angiolite BTK trial, 6 month Data) (P. Goverde)

angiolite BTK

öffnen

LOCOMOTIVE All Comers Registry with the Multi-Loc spot stenting device: 12-month results (K. Amendt)

VascuFlex® Multi-LOC

öffnen

MAKE COMBINATION THERAPY GREAT AGAIN DCBS AND AND SPOT STENTS IN FEMPOP LESIONS (G. Tepe)

VascuFlex® Multi-LOC

öffnen

LINC 2017 - Leipzig Interventional Course

New manufacturing process and stent design are key elements to improve clinical outcome (P. Goverde)

iVolution

öffnen

First 6-month results in 75 patients in the EVOLUTION study (M. Bosiers)

iVolution

öffnen

LUMINOR registry: a real world experience with a new DEB in advanced limb ischemia (V. Riambau)

luminor

öffnen

EffPac – Trial: Assessment of the Effectiveness of DCB versus POBA in the SFA (U. Teichgräber)

luminor

öffnen